Detalhe da pesquisa
1.
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
Clin Trials
; 21(2): 189-198, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877369
2.
Tolerance of dinutuximab therapy for treatment of high-risk neuroblastoma in two patients with end-stage renal disease on dialysis.
Pediatr Blood Cancer
; 68(3): e28852, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33381917
3.
A safety and feasibility trial of 131 I-MIBG in newly diagnosed high-risk neuroblastoma: A Children's Oncology Group study.
Pediatr Blood Cancer
; 68(10): e29117, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34028986
4.
Prognostic significance of pretreatment 18F-FDG positron emission tomography/computed tomography in pediatric neuroblastoma.
Pediatr Radiol
; 51(8): 1400-1405, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33629142
5.
Sentinel lymph node biopsy in head and neck rhabdomyosarcoma.
Pediatr Blood Cancer
; 66(3): e27532, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30393936
6.
Change in liver, spleen and bone marrow magnetic resonance imaging signal intensity over time in children with solid abdominal tumors.
Pediatr Radiol
; 48(3): 325-332, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29260287
7.
Single and multidimensional measurements underestimate neuroblastoma response to therapy.
Pediatr Blood Cancer
; 64(1): 18-24, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27440309
8.
MIBG in Neuroblastoma Diagnostic Imaging and Therapy.
Radiographics
; 36(1): 258-78, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26761540
9.
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
Neuro Oncol
; 25(10): 1883-1894, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115514
10.
Progression-Free Survival and Patterns of Response in Patients With Relapsed High-Risk Neuroblastoma Treated With Irinotecan/Temozolomide/Dinutuximab/Granulocyte-Macrophage Colony-Stimulating Factor.
J Clin Oncol
; 41(3): 508-516, 2023 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206505
11.
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Nat Med
; 29(6): 1379-1388, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37188782
12.
Molecular therapies for tuberous sclerosis and neurofibromatosis.
Curr Neurol Neurosci Rep
; 12(3): 294-301, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22544507
13.
Examining Violence Against Women at a Regional Level 1 Trauma Center During the COVID-19 Pandemic.
Am Surg
; 88(3): 404-408, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34645329
14.
Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.
Neuro Oncol
; 24(11): 1978-1988, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467749
15.
Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG).
Neuro Oncol
; 24(10): 1776-1789, 2022 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395680
16.
Management of neurofibromatosis type 1-associated plexiform neurofibromas.
Neuro Oncol
; 24(11): 1827-1844, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657359
17.
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Neuro Oncol
; 24(11): 1845-1856, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788692
18.
Use of sentinel node biopsy for staging parameningeal rhabdomyosarcoma.
Pediatr Blood Cancer
; 57(3): 520-3, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21744475
19.
NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.
J Clin Oncol
; 39(7): 797-806, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33507822
20.
Myeloablative Busulfan/Melphalan Consolidation following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma: Children's Oncology Group Trial ANBL12P1.
Transplant Cell Ther
; 27(6): 490.e1-490.e8, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823167